These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2548251)

  • 1. [Cerebral MRT in neurofibromatosis: gliosis versus neoplasia?].
    Mautner VF; Pressler M; Fünsterer C; Schneider E
    Rofo; 1989 Aug; 151(2):225-8. PubMed ID: 2548251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis type 1: diffusion weighted imaging findings of brain.
    Alkan A; Sigirci A; Kutlu R; Ozcan H; Erdem G; Aslan M; Ates O; Yakinci C; Egri M
    Eur J Radiol; 2005 Nov; 56(2):229-34. PubMed ID: 15963674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spontaneous regression of basal ganglia lesions in a case of neurofibromatosis type 1 (case report)].
    Oztürk M; Ozyazgan I; Mavili E; Orhan S
    Tani Girisim Radyol; 2003 Dec; 9(4):439-42. PubMed ID: 14730952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous regression of multicentric pilocytic astrocytoma with CSF dissemination in an adult.
    Sakai K; Miyahara T; Tsutsumi K; Kaneko T; Fukushima M; Tanaka Y; Hongo K
    Brain Tumor Pathol; 2011 Apr; 28(2):151-6. PubMed ID: 21210237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
    Magnaldi S; White RM; Bryan RN
    Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.
    Mirowitz SA; Sartor K; Gado M
    AJR Am J Roentgenol; 1990 Feb; 154(2):369-73. PubMed ID: 2105032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical relevance of signal-intense foci in cerebral magnetic resonance tomography in neurofibromatosis].
    Mautner VF; Schneider E; Fabra M; Laute S; Fünsterer C; Pressler M
    Fortschr Neurol Psychiatr; 1991 Jan; 59(1):25-30. PubMed ID: 1901049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential?
    Griffiths PD; Blaser S; Mukonoweshuro W; Armstrong D; Milo-Mason G; Cheung S
    Pediatrics; 1999 Oct; 104(4):e49. PubMed ID: 10506274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral pulvinar signal intensity decrease on T2-weighted images in patients with aspartylglucosaminuria.
    Autti T; Lönnqvist T; Joensuu R
    Acta Radiol; 2008 Jul; 49(6):687-92. PubMed ID: 18568562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain.
    DiPaolo DP; Zimmerman RA; Rorke LB; Zackai EH; Bilaniuk LT; Yachnis AT
    Radiology; 1995 Jun; 195(3):721-4. PubMed ID: 7754001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-neoplastic brain abnormalities on MRI in children and adolescents with neurofibromatosis type 1.
    Raininko R; Thelin L; Eeg-Olofsson O
    Neuropediatrics; 2001 Oct; 32(5):225-30. PubMed ID: 11748492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MR tomography of astrocytic tumors (I-III)].
    Pedrosa P; Grigat M; Higer HP; Straube U; Schaeben W; Gutjahr P; Voth D; Kunze S
    Rofo; 1989 Jan; 150(1):52-7. PubMed ID: 2536497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topographical alterations of the midbrain and the substantia nigra following unilateral posteroventral pallidotomy in patients with Parkinson's disease using routine and multishot diffusion-weighted magnetic resonance imaging.
    Adachi M; Kurimura M; Saito S; Hosoya T; Kayama T; Kato T
    Neuroradiology; 2002 Jul; 44(7):579-85. PubMed ID: 12136359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MR spectroscopy in the differential diagnosis of focal brain lesions in neurofibromatosis type 1 patients].
    Alkan A; Kutlu R; Siğirci A; Baysal T; Altinok T; Dusak A; Saraç K
    Tani Girisim Radyol; 2003 Jun; 9(2):166-70. PubMed ID: 14661483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diffusion weighted MR: principles and clinical use in selected brain diseases].
    Nistri M; Mascalchi M; Moretti M; Tessa C; Politi LS; Orlandi I; Pellicanò G; Villari N
    Radiol Med; 2000 Dec; 100(6):470-9. PubMed ID: 11307509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Magnetic resonance in the study of cerebral gliomas].
    Vaghi MA; Visciani A; Passerini A; Longone V; Broggi G
    Radiol Med; 1986 Jun; 72(6):431-8. PubMed ID: 3012662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma].
    Chen J; Xia J; Zhou YC; Xia LM; Zhu WZ; Zou ML; Feng DY; Wang CY
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):309-11. PubMed ID: 15996330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cranial MR imaging in patients with von Recklinghausen's disease (neurofibromatosis type I).
    Hashimoto T; Tayama M; Miyazaki M; Kuroda Y; Hiura K; Hujino K; Yamashita K
    Neuropediatrics; 1990 Nov; 21(4):193-8. PubMed ID: 2127081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clues and pitfalls in stereotactic biopsy of the central nervous system.
    Taratuto AL; Sevlever G; Piccardo P
    Arch Pathol Lab Med; 1991 Jun; 115(6):596-602. PubMed ID: 2039344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.